Skip to main content
Print

Medications for Non-Small Cell Lung Cancer

Other names: Cancer, Lung, Non-Small Cell; Lung Cancer, Non-Small Cell; NSCLC

Non-Small Cell Lung Cancer is cancer of the lung which is not small cell carcinoma.

Drugs used to treat Non-Small Cell Lung Cancer

The following list of medications are in some way related to or used in the treatment of this condition.

Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
Tarceva 8.5 39 reviews
Rx D N

Generic name: erlotinib systemic

Drug class: EGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Avastin 8.0 1 review
Rx C N

Generic name: bevacizumab systemic

Drug class: VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Opdivo 4.6 30 reviews
Rx N

Generic name: nivolumab systemic

Drug class: anti-PD-1 monoclonal antibodies

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Alimta 8.0 1 review
Rx D N

Generic name: pemetrexed systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

erlotinib 8.5 39 reviews
Rx D N

Generic name: erlotinib systemic

Brand name:  Tarceva

Drug class: EGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Xalkori 9.3 4 reviews
Rx D N

Generic name: crizotinib systemic

Drug class: multikinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Tagrisso 6.7 24 reviews
Rx N

Generic name: osimertinib systemic

Drug class: EGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Alecensa 9.0 1 review
Rx N

Generic name: alectinib systemic

Drug class: multikinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

bevacizumab 8.0 1 review
Rx C N

Generic name: bevacizumab systemic

Brand names:  Avastin, Zirabev, Mvasi, Alymsys …show all

Drug class: VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph

nivolumab 4.9 42 reviews
Rx N

Generic name: nivolumab systemic

Brand name:  Opdivo

Drug class: anti-PD-1 monoclonal antibodies

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph

Gilotrif 10 1 review
Rx D N

Generic name: afatinib systemic

Drug class: multikinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

methotrexate Rate Add review
Rx X N X

Generic name: methotrexate systemic

Brand name:  Trexall

Drug class: antimetabolites, antirheumatics, antipsoriatics, other immunosuppressants

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

osimertinib 6.8 26 reviews
Rx N

Generic name: osimertinib systemic

Brand name:  Tagrisso

Drug class: EGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph

crizotinib 7.8 6 reviews
Rx D N

Generic name: crizotinib systemic

Brand name:  Xalkori

Drug class: multikinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph

afatinib 7.7 3 reviews
Rx D N

Generic name: afatinib systemic

Brand name:  Gilotrif

Drug class: multikinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph

alectinib 9.0 1 review
Rx N

Generic name: alectinib systemic

Brand name:  Alecensa

Drug class: multikinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph

ceritinib 5.0 1 review
Rx D N

Generic name: ceritinib systemic

Brand name:  Zykadia

Drug class: multikinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph

Zykadia Rate Add review
Rx D N

Generic name: ceritinib systemic

Drug class: multikinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Alunbrig Rate Add review
Rx N

Generic name: brigatinib systemic

Drug class: multikinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Lumakras Rate Add review
Rx N

Generic name: sotorasib systemic

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

brigatinib Rate Add review
Rx N

Generic name: brigatinib systemic

Brand name:  Alunbrig

Drug class: multikinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph

Exkivity Rate Add review
Rx N

Generic name: mobocertinib systemic

Drug class: EGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Retevmo 10 1 review
Rx N

Generic name: selpercatinib systemic

Drug class: multikinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

sotorasib Rate Add review
Rx N

Generic name: sotorasib systemic

Brand name:  Lumakras

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph

capmatinib Rate Add review
Rx N

Generic name: capmatinib systemic

Brand name:  Tabrecta

Drug class: multikinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph

Frequently asked questions

View more FAQ

Learn more about Non-Small Cell Lung Cancer

Care guides

Symptoms and treatments

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer